Your browser doesn't support javascript.
loading
Silibinin to improve cancer therapeutic, as an apoptotic inducer, autophagy modulator, cell cycle inhibitor, and microRNAs regulator.
Jahanafrooz, Zohreh; Motamed, Nasrin; Rinner, Beate; Mokhtarzadeh, Ahad; Baradaran, Behzad.
Afiliación
  • Jahanafrooz Z; Department of Cell and Molecular Biology, Faculty of Science, University of Maragheh, Maragheh, Iran; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Motamed N; Department of Cellular and Molecular Biology, School of Biology, College of Science, University of Tehran, Tehran, Iran.
  • Rinner B; Division of Biomedical Research, Medical University Graz, Graz, Austria.
  • Mokhtarzadeh A; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Biotechnology, Higher Education Institute of Rab-Rashid, Tabriz, Iran. Electronic address: mokhtarzadehah@tbzmed.ac.ir.
  • Baradaran B; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. Electronic address: baradaranb@tbzmed.ac.ir.
Life Sci ; 213: 236-247, 2018 Nov 15.
Article en En | MEDLINE | ID: mdl-30308184
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Silibina / Neoplasias Límite: Animals / Humans Idioma: En Revista: Life Sci Año: 2018 Tipo del documento: Article País de afiliación: Irán
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Silibina / Neoplasias Límite: Animals / Humans Idioma: En Revista: Life Sci Año: 2018 Tipo del documento: Article País de afiliación: Irán